Lukas J. Motloch

Lukas J. Motloch

Auto-generated profile, based on publicly available information

Lukas J. Motloch

Paracelsus Medical University of Salzburg, Salzburg, Austria

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ATAlbert Topf
Albert Topf
TPThomas Pleininger
Thomas Pleininger
LMLukas J. Motloch
Lukas J. Motloch
Moritz MirnaMoritz Mirna
Moritz Mirna
Kristen Laura KoppKristen Laura Kopp
Kristen Laura Kopp
Hermann SalmhoferHermann Salmhofer
Hermann Salmhofer
Treatment-refractory hypothyroidism is a common clinical finding. Substantial causes include poor compliance and intake failure as well as gastrointestinal diseases, such as inflammatory bowel disease and short bowel syndromes. Increasing oral dosage of levothyroxine (LT4) is not always effective. Therefore, alternative routes of administration are necessary. In this report, we evaluate alternative treatment modalities for refractory hypothyroidism and present a 28-year-old woman with intestinal drug malabsorption successfully treated by subcutaneous LT4 administration. In this patient, a parenteral form of LT4, 500 μg/5 ml, was administered subcutaneously in a split dosage regimen. Blood hormone levels returned to normal within a few days and remained stable over an 8-month follow-up period.